Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.66 USD | +0.71% | +6.39% | -44.13% |
05-01 | Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration | MT |
05-01 | Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.13% | 462M | |
+25.64% | 48.09B | |
+46.90% | 40.62B | |
-3.46% | 40.43B | |
-6.20% | 28.36B | |
+9.17% | 24.89B | |
-20.42% | 19.01B | |
+28.06% | 12.09B | |
+0.19% | 11.88B | |
-1.24% | 11.8B |
- Stock Market
- Equities
- EDIT Stock
- News Editas Medicine, Inc.
- Editas Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021